Cigna Group DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NYSE
The Cigna Group reports robust 2025 financial results, outlines strategic advancements, and announces a planned CEO succession for July 1, 2026.
NYSE
The Cigna Group's 2025 Annual Meeting will be held virtually on April 23, 2025, and shareholders are encouraged to review proxy materials and vote on key proposals.
NYSE
The Cigna Group reports strong revenue growth and strategic advancements in 2024, while addressing challenges in medical costs and setting future performance targets.
NYSE
The Cigna Group is urging shareholders to vote on director elections, executive compensation, auditor ratification, and shareholder proposals at the upcoming annual meeting on April 24, 2024.
NYSE
The Cigna Group is urging shareholders to vote on director elections, executive compensation, auditor ratification, and two shareholder proposals at the Annual Meeting on April 24, 2024.
NYSE
The Cigna Group's 2024 Annual Meeting will be held virtually on April 24, 2024, with shareholders able to vote on key proposals including the election of directors and executive compensation.
NYSE
The Cigna Group reports strong 2023 financial performance and outlines strategic priorities for continued growth and shareholder value in 2024.